These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 27161253)

  • 41. Immunohistochemical and molecular genetics study of a granular cell astrocytoma: a case report of malignant transformation to a glioblastoma.
    Ishii T; Mizukawa K; Sasayama T; Sasaki H; Hayashi S; Nakamizo S; Tanaka H; Tanaka K; Hara S; Hirai C; Itoh T; Kohmura E
    Neuropathology; 2013 Jun; 33(3):299-305. PubMed ID: 22994265
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Isocitrate dehydrogenase 1 R132H mutation is not detected in angiocentric glioma.
    Raghunathan A; Olar A; Vogel H; Parker JR; Coventry SC; Debski R; Albarracin CT; Aldape KD; Cahill DP; Powell SZ; Fuller GN
    Ann Diagn Pathol; 2012 Aug; 16(4):255-9. PubMed ID: 22445362
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Modelling MR and clinical features in grade II/III astrocytomas to predict IDH mutation status.
    Hyare H; Rice L; Thust S; Nachev P; Jha A; Milic M; Brandner S; Rees J
    Eur J Radiol; 2019 May; 114():120-127. PubMed ID: 31005161
    [TBL] [Abstract][Full Text] [Related]  

  • 44. IDH1 mutation is associated with improved overall survival in patients with glioblastoma: a meta-analysis.
    Cheng HB; Yue W; Xie C; Zhang RY; Hu SS; Wang Z
    Tumour Biol; 2013 Dec; 34(6):3555-9. PubMed ID: 23904262
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Rare IDH1 variants are common in pediatric hemispheric diffuse astrocytomas and frequently associated with Li-Fraumeni syndrome.
    Sumerauer D; Krskova L; Vicha A; Misove A; Mamatjan Y; Jencova P; Vlckova M; Slamova L; Vanova K; Liby P; Taborsky J; Koblizek M; Klubal R; Kyncl M; Zadeh G; Stary J; Zamecnik J; Ramaswamy V; Zapotocky M
    Acta Neuropathol; 2020 Apr; 139(4):795-797. PubMed ID: 31897644
    [No Abstract]   [Full Text] [Related]  

  • 46. IDH1 mutations as molecular signature and predictive factor of secondary glioblastomas.
    Nobusawa S; Watanabe T; Kleihues P; Ohgaki H
    Clin Cancer Res; 2009 Oct; 15(19):6002-7. PubMed ID: 19755387
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Distribution of EGFR amplification, combined chromosome 7 gain and chromosome 10 loss, and TERT promoter mutation in brain tumors and their potential for the reclassification of IDHwt astrocytoma to glioblastoma.
    Stichel D; Ebrahimi A; Reuss D; Schrimpf D; Ono T; Shirahata M; Reifenberger G; Weller M; Hänggi D; Wick W; Herold-Mende C; Westphal M; Brandner S; Pfister SM; Capper D; Sahm F; von Deimling A
    Acta Neuropathol; 2018 Nov; 136(5):793-803. PubMed ID: 30187121
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The effect of IDH1 mutation on the structural connectome in malignant astrocytoma.
    Kesler SR; Noll K; Cahill DP; Rao G; Wefel JS
    J Neurooncol; 2017 Feb; 131(3):565-574. PubMed ID: 27848136
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Targeted copy number analysis outperforms histologic grading in predicting patient survival for WHO grades II/III IDH-mutant astrocytomas.
    Cimino PJ; Holland EC
    Neuro Oncol; 2019 Jun; 21(6):819-821. PubMed ID: 30918961
    [No Abstract]   [Full Text] [Related]  

  • 50. Gain of 12p encompassing CCND2 is associated with gemistocytic histology in IDH mutant astrocytomas.
    Sahm F; Korshunov A; Schrimpf D; Stichel D; Jones DT; Capper D; Koelsche C; Reuss D; Kratz A; Huang K; Wefers AK; Schick M; Bewerunge-Hudler M; Mittelbronn M; Platten M; Hänggi D; Jeibmann A; Unterberg A; Herold-Mende C; Pfister SM; Brandner S; Wick W; von Deimling A
    Acta Neuropathol; 2017 Feb; 133(2):325-327. PubMed ID: 28000032
    [No Abstract]   [Full Text] [Related]  

  • 51. Diffusely infiltrating astrocytomas: pathology, molecular mechanisms and markers.
    Ichimura K; Narita Y; Hawkins CE
    Acta Neuropathol; 2015 Jun; 129(6):789-808. PubMed ID: 25975377
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinicopathologic features of small cell glioblastomas.
    Takeuchi H; Kitai R; Hosoda T; Yamada S; Hashimoto N; Kikuta K; Shimizu Y; Kimura H
    J Neurooncol; 2016 Apr; 127(2):337-44. PubMed ID: 26725094
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Distinct Histomorphology in Molecular Subgroups of Glioblastomas in Young Patients.
    Neumann JE; Dorostkar MM; Korshunov A; Mawrin C; Koch A; Giese A; Schüller U
    J Neuropathol Exp Neurol; 2016 May; 75(5):408-14. PubMed ID: 26975364
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Immunohistochemical demonstration of isocitrate dehydrogenase 1 (IDH1) mutation in a small subset of prostatic carcinomas.
    Mauzo SH; Lee M; Petros J; Hunter S; Chang CM; Shu HK; Bellail AC; Hao C; Cohen C
    Appl Immunohistochem Mol Morphol; 2014 Apr; 22(4):284-7. PubMed ID: 23235339
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Gemistocytic astrocytomas].
    Matsko DE; Zrelov AA; Ulitin AY; Matsko MV; Skliar SS; Baksheeva AO; Imyanitov EN
    Arkh Patol; 2018; 80(4):27-38. PubMed ID: 30059069
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Nf1;Trp53 mutant mice develop glioblastoma with evidence of strain-specific effects.
    Reilly KM; Loisel DA; Bronson RT; McLaughlin ME; Jacks T
    Nat Genet; 2000 Sep; 26(1):109-13. PubMed ID: 10973261
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Malignant transformation of a pleomorphic xanthoastrocytoma.
    Dickerman RD
    Acta Neurochir (Wien); 2006 Jan; 148(1):98. PubMed ID: 16369863
    [No Abstract]   [Full Text] [Related]  

  • 58. T2 mapping of the peritumoral infiltration zone of glioblastoma and anaplastic astrocytoma.
    Auer TA; Kern M; Fehrenbach U; Tanyldizi Y; Misch M; Wiener E
    Neuroradiol J; 2021 Oct; 34(5):392-400. PubMed ID: 33573473
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comprehensive portrait of recurrent glioblastoma multiforme in molecular and clinical characteristics.
    Li R; Chen X; You Y; Wang X; Liu Y; Hu Q; Yan W
    Oncotarget; 2015 Oct; 6(31):30968-74. PubMed ID: 26427041
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Genetic analysis of a case of glioblastoma with oligodendroglial component arising during the progression of diffuse astrocytoma.
    Hata N; Suzuki SO; Murata H; Hatae R; Akagi Y; Sangatsuda Y; Amano T; Yoshimoto K; Tahira T; Mizoguchi M
    Pathol Oncol Res; 2015 Jul; 21(3):839-43. PubMed ID: 25354913
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.